PFE Articles, Pfizer Inc. - From 01/05/24

The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and affo...

Around 15% of Americans said they were planning to participate this year in Dry January — a month of abstinence from alcohol — according to a s...

In a year when equity markets rallied strongly, short sellers — traders who position for losses on assets — had an extremely tough time in 2023...

Stocks have experienced a shaky beginning in 2024, with initial losses followed by slight gains on Thursday. However, Marc Chaikin, founder and CEO...

During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc. as...

Just as large pharma companies prepare a showdown with Medicare's newfound power to negotiate down drug prices, several major drug companies ar...

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...

2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first...

CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the ...

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023. ...